Skip to main content

Advertisement

SpringerLink
Log in

Update on the Costs of Chronic Rhinosinusitis

  • Rhinology (R. Orlandi, Section Editor)
  • Published:
Current Otorhinolaryngology Reports Aims and scope Submit manuscript

Abstract

Chronic rhinosinusitis (CRS) is an under-recognized and highly prevalent chronic disease affecting 5–15 % of the population. Recently, there has been a growing awareness of the significant economic burden associated with the long-term medical and surgical management of CRS. In the context of exponentially increasing and unsustainable health care spending, there is an urgent need to better define the costs associated with the care of these patients in order to develop treatment strategies that increase the quality and value of care to patients. This review will provide readers with an introduction to health care costs then discuss the costs associated with the management of CRS, emphasizing key studies that have defined these costs. Understanding the sources of these costs is a crucial first step towards eventually improving the value of care for this ubiquitous chronic inflammatory disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Porter ME. A strategy for health care reform—toward a value-based system. N Engl J Med. 2009;361(2):109–12.

    Article  CAS  PubMed  Google Scholar 

  2. •• Porter ME. What is value in health care? N Engl J Med 2010:363(26):2477–81. This is an excellent article describing the concepts involved in increasing ‘value’ in health care. It defines value and outlines potential strategies to create the correct type of competition, which is based on patients outcomes, to improve value of health care interventions.

  3. Liu CC, et al. Systematic review of the quality of economic evaluations in the otolaryngology literature. Otolaryngol Head Neck Surg. 2015;152:106–15.

    Article  PubMed  Google Scholar 

  4. • Smith KA, Rudmik L. Cost collection and analysis for health economic evaluation. Otolaryngol Head Neck Surg 2013:149(2):192–9. This is an important review to improve the understanding of how to appropriately collect, report, and interpret cost outcomes within the context of health care delivery. The information is particularly helpful for investigators wishing to perform a health economic evaluation.

  5. Berger M, et al. Health care cost, quality and outcomes: ISPOR book of terms 2003. Lawrenceville: International Society for Pharmacoeconomics and Outcomes Research; 2003.

    Google Scholar 

  6. Halawi AM, Smith SS, Chandra RK. Chronic rhinosinusitis: epidemiology and cost. Allergy Asthma Proc. 2013;34(4):328–34.

    Article  PubMed  Google Scholar 

  7. Rudmik L, Smith TL. Quality of life in patients with chronic rhinosinusitis. Curr Allergy Asthma Rep. 2011;11(3):247–52.

    Article  PubMed  Google Scholar 

  8. Soler ZM, et al. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011;121(12):2672–8.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Alt JA, Smith TL. Chronic rhinosinusitis and sleep: a contemporary review. Int Forum Allergy Rhinol. 2013;3(11):941–9.

    Article  PubMed  Google Scholar 

  10. Alt JA, et al. Sleep quality and disease severity in patients with chronic rhinosinusitis. Laryngoscope. 2013;123(10):2364–70.

    PubMed Central  PubMed  Google Scholar 

  11. Soler ZM, Mace J, Smith TL. Symptom-based presentation of chronic rhinosinusitis and symptom-specific outcomes after endoscopic sinus surgery. Am J Rhinol. 2008;22(3):297–301.

    Article  PubMed  Google Scholar 

  12. Rank MA, et al. Acute exacerbations of chronic rhinosinusitis occur in a distinct seasonal pattern. J Allergy Clin Immunol. 2010;126(1):168–9.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Chester AC, et al. Systematic review of change in bodily pain after sinus surgery. Otolaryngol Head Neck Surg. 2008;139(6):759–65.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Kang JH, et al. Chronic rhinosinusitis increased the risk of stroke: a 5-year follow-up study. Laryngoscope. 2013;123(4):835–40.

    Article  PubMed  Google Scholar 

  15. Wu CW, et al. Risk of stroke among patients with rhinosinusitis: a population-based study in Taiwan. Am J Rhinol Allergy. 2012;26(4):278–82.

    Article  CAS  PubMed  Google Scholar 

  16. Kariya S, et al. Chronic rhinosinusitis patients have decreased lung function. Int Forum Allergy Rhinol. 2014;4(10):828–33.

    Article  PubMed  Google Scholar 

  17. Katotomichelakis M, et al. Demographic correlates of anxiety and depression symptoms in chronic sinonasal diseases. Int J Psychiatry Med. 2014;48(2):83–94.

    Article  PubMed  Google Scholar 

  18. Tomljenovic D, Pinter D, Kalogjera L. Perceived stress and severity of chronic rhinosinusitis in allergic and nonallergic patients. Allergy Asthma Proc. 2014;35(5):398–403.

    Article  PubMed  Google Scholar 

  19. • Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol 2011:120(7):423–7. The results from this large administrative database research study have provided the most accurate overall direct cost of CRS to the US health care system. It demonstrated an annual overall direct health care cost of $8.6 billion (adjusted 2014 USD $9.9 billion).

  20. • Rudmik L, et al. Productivity costs in patients with refractory chronic rhinosinusitis. Laryngoscope 2014:124(9):2007–12. This is the first prospective study quantifying the indirect costs of patients with refractory CRS. It demonstrated that the annual productivity cost was approximately $10,000 per patient and an overall indirect cost of $12 billion to the US society.

  21. Benninger MS, Holy CE. Endoscopic sinus surgery provides effective relief as observed by health care use pre- and postoperatively. Otolaryngol Head Neck Surg. 2014;150(5):893–900.

    Article  PubMed  Google Scholar 

  22. Benninger MS, Holy CE. The impact of endoscopic sinus surgery on health care use in patients with respiratory comorbidities. Otolaryngol Head Neck Surg. 2014;151(3):508–15.

    Article  PubMed  Google Scholar 

  23. Gliklich RE, Metson R. Economic implications of chronic sinusitis. Otolaryngol Head Neck Surg. 1998;118(3 Pt 1):344–9.

    Article  CAS  PubMed  Google Scholar 

  24. Holy CE, et al. The impact of balloon catheter dilation on frequency of sinus surgery in the United States. Med Devices (Auckl). 2014;7:83–9.

    Article  Google Scholar 

  25. Chung SD, et al. Health care service utilization among patients with chronic rhinosinusitis: a population-based study. Laryngoscope. 2014;124(6):1285–9.

    Article  PubMed  Google Scholar 

  26. Bhattacharyya N. The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol. 2003;17(1):27–32.

    PubMed  Google Scholar 

  27. Bhattacharyya N, et al. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg. 2011;144(3):440–5.

    Article  PubMed  Google Scholar 

  28. Au J, Rudmik L. Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach. Int Forum Allergy Rhinol. 2013;3(9):748–54.

    Article  PubMed  Google Scholar 

  29. Chatterjee S, Laxminarayan R. Costs of surgical procedures in Indian hospitals. BMJ Open. 2013;3:6.

    Article  Google Scholar 

  30. Rudmik L, et al. Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015;125:25–32.

    Article  PubMed  Google Scholar 

  31. Weinstein MC. How much are Americans willing to pay for a quality-adjusted life year? Med Care. 2008;46(4):343–5.

    Article  PubMed  Google Scholar 

  32. Shiroiwa T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422–37.

    Article  PubMed  Google Scholar 

  33. •• Rudmik L, Drummond M. Health economic evaluation: important principles and methodology. Laryngoscope 2013;123(6):1341–7. With increasing emphasis being placed onto the value and cost-effectiveness of medical and surgical interventions, clinicians need to obtain knowledge of economic evaluation methodology and interpretation. This article is an excellent resource to review basic cost-effectiveness analysis, health-state utility metrics, controversies with using the quality-adjusted life year, and common pitfalls.

  34. Hanna BM, Kilty SJ. Middle turbinate suture technique: a cost-saving and effective method for middle meatal preservation after endoscopic sinus surgery. J Otolaryngol Head Neck Surg. 2012;41(6):407–12.

    PubMed  Google Scholar 

  35. Rudmik L, Smith TL. Economic evaluation of a steroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2014;151(2):359–66.

    Article  PubMed  Google Scholar 

  36. Yeh DH, et al. The utility of routine polyp histopathology after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2014;4:11.

    Article  Google Scholar 

  37. Desrosiers M, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2011;40(Suppl 2):S99–193.

    PubMed  Google Scholar 

  38. Fokkens WJ, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12.

    PubMed  Google Scholar 

  39. Rosenfeld RM, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(3 Suppl):S1–31.

    Article  PubMed  Google Scholar 

  40. Leung RM, et al. Primary care and upfront computed tomography scanning in the diagnosis of chronic rhinosinusitis: a cost-based decision analysis. Laryngoscope. 2014;124(1):12–8.

    Article  PubMed  Google Scholar 

  41. Tan BK, et al. Effect of symptom-based risk stratification on the costs of managing patients with chronic rhinosinusitis symptoms. Int Forum Allergy Rhinol. 2013;3(11):933–40.

    Article  PubMed  Google Scholar 

  42. Akdis CA, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479–90.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Otolaryngology – Head and Neck Surgery, Department of Surgery, University of Calgary, Foothills Medical Centre, South Tower Suite 602, 1403 – 29th St. NW, Calgary, AB, T2N 2T9, Canada

    Kristine A. Smith & Luke Rudmik

Authors
  1. Kristine A. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luke Rudmik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luke Rudmik.

Additional information

This article is part of the Topical Collection on Rhinology.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, K.A., Rudmik, L. Update on the Costs of Chronic Rhinosinusitis. Curr Otorhinolaryngol Rep 3, 87–93 (2015). https://doi.org/10.1007/s40136-015-0076-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40136-015-0076-y

Keywords

Search

Navigation